Gyre Therapeutics
GYRE
GYRE
27 hedge funds and large institutions have $2.15M invested in Gyre Therapeutics in 2016 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
56% less capital invested
Capital invested by funds: $4.9M → $2.15M (-$2.75M)
Holders
27
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$129K | |
| 2 | +$25K | |
| 3 | +$15K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$15K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$13.2K |
Top Sellers
| 1 | -$1.05M | |
| 2 | -$86K | |
| 3 | -$72K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$66.2K |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$30K |